Skip to content
OpenCapital
Get started

Danaher DHR Life Sciences — Goodwill

Other segment segments

Biotechnology
$22.73B-1.8%
Diagnostics
$11.91B—

Similar metrics at other companies

Ashland logo
ASHLife Sciences — Goodwill
$462M-42.8%
Revvity logo
RVTYLife Sciences — Goodwill
$4.75B+3.9%
Donaldson Company logo
DCILife Sciences Segment — Goodwill
$172.8M+2.2%
RCM Technologies logo
RCMTLife Sciences Data Solutions — Goodwill
$7.83M0.0%
Bio-Rad Laboratories logo
BIOLife Science — Goodwill
$490.5M+47.2%
ExlService Holdings logo
EXLSHealthcare and Life Sciences — Goodwill
$189.57M0.0%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's life sciences — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's life sciences — goodwill?
Danaher (DHR) reported life sciences — goodwill of $12.78B in Q2 2026.
How has Danaher's life sciences — goodwill changed year-over-year?
Danaher's life sciences — goodwill decreased by 0.8% year-over-year, from $12.88B to $12.78B.
What is the long-term trend for Danaher's life sciences — goodwill?
Over 4 years (2021 to 2025), Danaher's life sciences — goodwill has grown at a -18.3% compound annual growth rate (CAGR), from $114.76B to $51.08B.
What does life sciences — goodwill mean?
The premium paid over the fair value of net assets during the acquisition of businesses within the Life Sciences segment. It represents intangible benefits such as brand reputation, customer relationships, and synergies. This balance is subject to periodic impairment testing to ensure it remains supported by the segment's future cash flows.